Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of atezolizumab (Anti-PD-L1) in the treatment of relapsed/refractory IIB/IVB mycosis fungoides/Sézary syndrome patients after previous systemic treatment. EORTC-1652-CLTG "PARCT".
Stadler R, Roccuzzo G, Ortiz-Romero P, Bagot M, Quaglino P, Guenova E, Jonak C, Papadavid E, Stranzenbach R, Marreaud S, Musoro J, Casas-Martin J, Murray D, Drennan S, Hear JV, Moss P, Sartori D, Battistella M, Willemze R, Scarisbrick J, Knobler R. Stadler R, et al. Among authors: moss p. Eur J Cancer. 2025 Jun 3;222:115484. doi: 10.1016/j.ejca.2025.115484. Epub 2025 Apr 30. Eur J Cancer. 2025. PMID: 40319676 Free article. Clinical Trial.
A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial.
Cook JA, Patten PEM, Peckham N, Moss P, Phillips N, Abhishek A, Roberts T, Hodges M, Talbot G, Barber V, Francis A, Shields AM, Duley L, Hoogeboom R, Willett BJ, Scott S, Parry-Jones N, Eyre TA, Plested G, Vandici G, Wandroo FA, Hutchinson C, Paneesha S, Murray DJ, Martinez-Calle N, Jenkins S, Heartin E, Parry HM. Cook JA, et al. Among authors: moss p. Lancet Haematol. 2025 Apr;12(4):e294-e303. doi: 10.1016/S2352-3026(25)00008-0. Lancet Haematol. 2025. PMID: 40175001 Free article. Clinical Trial.
574 results